These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of single factor deficiencies: a case study approach. Marques MB Clin Lab Sci; 2003; 16(2):120-2. PubMed ID: 12757193 [No Abstract] [Full Text] [Related]
23. Acquired von Willebrand syndrome: from pathophysiology to management. Veyradier A; Jenkins CS; Fressinaud E; Meyer D Thromb Haemost; 2000 Aug; 84(2):175-82. PubMed ID: 10959686 [No Abstract] [Full Text] [Related]
24. Diagnosis and treatment of von Willebrand disease. Cox Gill J Hematol Oncol Clin North Am; 2004 Dec; 18(6):1277-99, viii. PubMed ID: 15511616 [TBL] [Abstract][Full Text] [Related]
25. Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus. Viallard JF; Pellegrin JL; Vergnes C; Borel-Derlon A; Clofent-Sanchez G; Nurden AT; Leng B; Nurden P Br J Haematol; 1999 May; 105(2):532-7. PubMed ID: 10233433 [TBL] [Abstract][Full Text] [Related]
26. Obstetric and gynaecological aspects of von Willebrand disease. Kouides PA Best Pract Res Clin Haematol; 2001 Jun; 14(2):381-99. PubMed ID: 11686106 [TBL] [Abstract][Full Text] [Related]
28. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. Jacquemin M Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355 [TBL] [Abstract][Full Text] [Related]
29. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology. Eikenboom JC Best Pract Res Clin Haematol; 2001 Jun; 14(2):365-79. PubMed ID: 11686105 [TBL] [Abstract][Full Text] [Related]
32. Bleeding and clotting: new therapies and old issues revisited. Lee CA; Aledort LM Haemophilia; 2009 Mar; 15(2):592-6. PubMed ID: 19335754 [No Abstract] [Full Text] [Related]
33. Von Willebrand: the scientist, the disease, the factor, and the treatment. Berntorp E; Lillicrap D Thromb Res; 2007; 120 Suppl 1():S1. PubMed ID: 17482240 [No Abstract] [Full Text] [Related]
34. [Hematology and dentistry. Part III. Fibrin formation disorder]. Huijgens PC Ned Tijdschr Tandheelkd; 1996 Mar; 103(3):86-7. PubMed ID: 11921952 [TBL] [Abstract][Full Text] [Related]
35. On the way to virus-safe blood coagulation factor concentrates. Schimpf K Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():15-24. PubMed ID: 12016574 [No Abstract] [Full Text] [Related]
38. Von Willebrand disease. Robertson J; Lillicrap D; James PD Pediatr Clin North Am; 2008 Apr; 55(2):377-92, viii-ix. PubMed ID: 18381092 [TBL] [Abstract][Full Text] [Related]
39. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. James AH; Kouides PA; Abdul-Kadir R; Edlund M; Federici AB; Halimeh S; Kamphuisen PW; Konkle BA; Martínez-Perez O; McLintock C; Peyvandi F; Winikoff R Am J Obstet Gynecol; 2009 Jul; 201(1):12.e1-8. PubMed ID: 19481722 [TBL] [Abstract][Full Text] [Related]
40. Women and inherited bleeding disorders: pregnancy and delivery. Kadir RA Semin Hematol; 1999 Jul; 36(3 Suppl 4):28-35. PubMed ID: 10513769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]